BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Creative Planning | 21,224 | $53,697 | 0.00% |
| ROYAL BANK OF CANADA | 3,057 | $7,000 | 0.00% |
| VANGUARD GROUP INC | 1,220,530 | $3,087,941 | 0.00% |
| Swiss National Bank | 44,200 | $111,826 | 0.00% |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 736 | $2 | 0.00% |
| Ameritas Investment Partners, Inc. | 1,350 | $3,416 | 0.00% |
| JANE STREET GROUP, LLC | 141,675 | $358,438 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 22,488 | $56,895 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 16,777 | $42,446 | 0.00% |
| Cubist Systematic Strategies, LLC | 2 | $5 | 0.00% |
| Point72 Asset Management, L.P. | 2,669 | $6,752 | 0.00% |
| UBS Group AG | 78,604 | $198,868 | 0.00% |
External links
This page lists BIOXCEL THERAPEUTICS INC's shareholders in Q3 2023. To view BIOXCEL THERAPEUTICS INC's shareholder history, click here.